Virtual substance use treatment company Pelago raised a $58 million Series C led by Atomico.
Why it matters:Getting treatments to patients remains an obstacle following pandemic-fueled record deaths from drug overdoses, alcohol and suicide — and research suggests virtual approaches might help.
